ATOSSA THERAPEUTICS, INC. Operating Lease, Liability, Current
ATOSSA THERAPEUTICS, INC. (ATOS) had Operating Lease, Liability, Current of $0 as of 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2022-02-28
- 2021-12-31: Operating Lease, Liability, Current $0.00.
- 2021-09-30: Operating Lease, Liability, Current $1.22K.
- 2021-06-30: Operating Lease, Liability, Current $4.72K.
- 2021-03-31: Operating Lease, Liability, Current $8.01K.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 | |
| 2021-09-30 | $1.22K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $4.72K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $8.01K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $18.00K 10-K · filed 2022-02-28 | $18.05K 10-K · filed 2021-03-31 |
| 2020-09-30 | $30.06K 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $39.52K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $29.39K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $39.37K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $49.27K 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $51.80K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $50.71K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |